Drug Shortage Report for TARO-MONTELUKAST
Report ID | 41756 |
Drug Identification Number | 02389517 |
Brand name | RAN-MONTELUKAST |
Common or Proper name | RAN-MONTELUKAST |
Company Name | SUN PHARMA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | MONTELUKAST |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | R03DC |
ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-03-05 |
Actual start date | 2018-03-05 |
Estimated end date | |
Actual end date | 2018-08-17 |
Shortage status | Resolved |
Updated date | 2018-08-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2018-08-23 | French | Compare |
v6 | 2018-08-23 | English | Compare |
v5 | 2018-03-22 | French | Compare |
v4 | 2018-03-22 | English | Compare |
v3 | 2018-03-06 | English | Compare |
v2 | 2018-03-05 | French | Compare |
v1 | 2018-03-05 | English | Compare |
Showing 1 to 7 of 7